The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Dec 2016 16:31

RNS Number : 0050S
Midatech Pharma PLC
15 December 2016
 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

 

Midatech Pharma Plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to thenotification obligation:

Legal & General (Unit Trust Managers) Limited (UTM)

Legal & General Investment Management Limited (LGIM)

 

4. Full name of shareholder(s)  (if different from 3.):

 

Legal & General Assurance Society Limited (LGAS & LGPL)

 

 

 

5. Date of the transaction and date onwhich the threshold is crossed orreached:

14 December 2016

6. Date on which issuer notified:

15 December 2016

7. Threshold(s) that is/are crossed orreached:

 

 

 

LGIM (Above 10%) UTM (Above 5%)

 

 

 

8. Notified details:

 

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

 

Numberof shares

Number of votingrights

% of voting rights

Direct

Indirect

Direct

Indirect

ORD GBP 0.00005

LGIM

 

 4,540,518.00

LGIM

 

 5,040,518

LGIM

 

 5,040,518

LGIM

 

10.35%

 

UTM

 

First Notification under DTR sourcebook

 

 

UTM

 

 

2,568,500

 

UTM

 

 

2,568,500

 

 

UTM

 

 

5.27%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

Expirationdate

 

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financialinstrument

 

 

Exercise price

 

Expiration date

 

Exercise/Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 5,040,518

LGIM

 

10.35%

 

 2,568,500

UTM

 

5.27%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group) ( 5,040,518 -10.35% = Total Position)

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect) ( 5,040,518 - 10.35% = Total Position)

Legal & General Investment Management Limited (Indirect) (LGIM) ( 5,040,518 - 10.35% = Total Position)

Legal & General (Unit Trust Managers) Limited ( 2,568,500 - 5.27% = UTM)

Legal & General Group Plc (Direct) (L&G)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD) (PMC)

Legal & General Insurance Holdings Limited (Direct) (LGIH) (LGAS & LGPL)

Legal & General Assurance (Pensions Management) Limited (PMC) (PMC)

Legal & General Assurance Society Limited (LGAS & LGPL) (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of  48,699,456

14. Contact name:

Victoria Davies (LGIM)

15. Contact telephone number:

029 2035 4147

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLTABFTMBTBBPF
Date   Source Headline
10th Mar 20169:00 amRNSNotice of Audited Full Year Results
29th Feb 20167:00 amRNSMidatech Celebrates Rare Disease Day
23rd Feb 20168:59 amRNSHolding(s) in Company
6th Jan 20167:00 amRNSPre-close Trading Update
4th Jan 20167:00 amRNSLicencing agreement signed with Emergex Vaccines
30th Dec 20157:00 amRNSClosing of product acquisition
23rd Dec 20157:00 amRNSIssue of Equity
18th Dec 20151:09 pmRNSDirector/PDMR Shareholding
18th Dec 20157:00 amRNSMidatech agrees to acquire Zuplenz®,
14th Dec 20157:00 amRNSAgreement with Centurion Pharma
9th Dec 20157:10 amRNSMidatech Appoints RBC as Joint Broker
7th Dec 20157:00 amRNSClosing of acquisition
3rd Dec 20152:34 pmRNSMerger Update: Amount of New Shares to be Issued
3rd Dec 20157:00 amRNSMerger Update: Acquisition of DARA BioSciences
19th Nov 20159:30 amRNSSupplemental Disclosure
25th Sep 20157:00 amRNSIssue of equity from exercise of share options
14th Sep 20157:00 amRNSHalf Yearly Report
2nd Sep 20159:10 amRNSMidatech to Present at Rodman & Renshaw Conference
2nd Sep 20157:00 amRNSNotice of Interim Results
13th Aug 20157:00 amRNSOcular Agreement with Ophthotech
12th Aug 20157:00 amRNSFiling of Form F-4 Registration Statement with SEC
23rd Jul 20157:00 amRNSInitiation of Phase IIa study of insulin delivery
26th Jun 201512:38 pmRNSDirector's Share Purchase
25th Jun 20153:03 pmRNSMidatech Pharma-Posting of Annual Financial Report
24th Jun 20157:00 amRNSDirector/PDMR Shareholding
23rd Jun 20153:43 pmRNSDirector/PDMR Shareholding
4th Jun 20157:00 amRNSProposed Acquisition of DARA BioSciences, Inc.
26th May 20152:05 pmRNSResult of AGM
26th May 20157:01 amRNSAnnual General Meeting
24th Apr 20154:12 pmRNSIssue of equity from exercise of share options
22nd Apr 20159:41 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
17th Apr 20157:04 amRNSPreliminary Results
14th Apr 20157:00 amRNSResearch Collaboration Signed
1st Apr 20157:00 amRNSMidatech Pharma - Board Change
31st Mar 20151:42 pmRNSChange of Registered Office Address
26th Mar 20157:00 amRNSNotice of Maiden Preliminary Results
23rd Mar 201510:43 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Mar 20157:00 amRNSResearch Collaboration Signed with Global Pharma
24th Feb 20157:00 amRNSTrading Update
19th Feb 20157:00 amRNSPositive Results in Proof-of-Concept Study
2nd Jan 20158:30 amRNSHolding(s) in Company
17th Dec 20147:00 amRNSAward of EU grant funding
9th Dec 20143:37 pmRNSHolding(s) in Company
8th Dec 201412:00 pmRNSMidatech Pharma acquires Q Chip

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.